Clinical Trials
2 trialsNCT03574649 2025-02-21
QUILT-2.024: Phase 2 Neoadjuvant, Consolidation, and Adjuvant Combination NANT Immunotherapy Versus Standard of Care in Subjects With Resectable Non-small Cell Lung Cancer
ImmunityBio, Inc.
Phase 2 Withdrawn
NCT00472771 2012-02-09
INNO-206 in Patients With Small Cell Lung Cancer (SCLC)
CytRx
Phase 2 Withdrawn